Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1996 Aug;34(8):1926–1929. doi: 10.1128/jcm.34.8.1926-1929.1996

Variation in metabolic enzyme activity of persistent Haemophilus influenzae in respiratory tracts of patients with cystic fibrosis.

L V Möller 1, H Grasselier 1, J Dankert 1, L van Alphen 1
PMCID: PMC229155  PMID: 8818883

Abstract

Haemophilus influenzae organisms were isolated from sputum specimens prospectively collected from 40 patients with cystic fibrosis during 2 years to study variations in the metabolic enzyme activities of persistent H. influenzae strains as determined by biotyping. In total, 97 distinct H. influenzae strains without variations in their major outer membrane protein (MOMP) patterns and 73 MOMP variants derived from 30 of these distinct strains were obtained. Twelve distinct strains and 42 MOMP variant strains were isolated at multiple time points during the study period, indicating the persistence of these strains. Among the 54 persistent H. influenzae strains, 22 (41%) strains with stable MOMP compositions showed random variations in biotypes. In 39 of 103 (38%) H. influenzae strains, biotype changes coincided with MOMP variations. Biotype variations were the result of both the loss and the acquisition of enzyme activities. The results of the study indicate that changes in metabolic enzyme activity occur randomly during the persistence of H. influenzae organisms in cystic fibrosis patients, irrespective of MOMP variations.

Full Text

The Full Text of this article is available as a PDF (246.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barth A. L., Pitt T. L. Auxotrophic variants of Pseudomonas aeruginosa are selected from prototrophic wild-type strains in respiratory infections in patients with cystic fibrosis. J Clin Microbiol. 1995 Jan;33(1):37–40. doi: 10.1128/jcm.33.1.37-40.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Duim B., van Alphen L., Eijk P., Jansen H. M., Dankert J. Antigenic drift of non-encapsulated Haemophilus influenzae major outer membrane protein P2 in patients with chronic bronchitis is caused by point mutations. Mol Microbiol. 1994 Mar;11(6):1181–1189. doi: 10.1111/j.1365-2958.1994.tb00394.x. [DOI] [PubMed] [Google Scholar]
  3. Gilligan P. H. Microbiology of airway disease in patients with cystic fibrosis. Clin Microbiol Rev. 1991 Jan;4(1):35–51. doi: 10.1128/cmr.4.1.35. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Groeneveld K., van Alphen L., Eijk P. P., Jansen H. M., Zanen H. C. Changes in outer membrane proteins of nontypable Haemophilus influenzae in patients with chronic obstructive pulmonary disease. J Infect Dis. 1988 Aug;158(2):360–365. doi: 10.1093/infdis/158.2.360. [DOI] [PubMed] [Google Scholar]
  5. Groeneveld K., van Alphen L., Eijk P. P., Visschers G., Jansen H. M., Zanen H. C. Endogenous and exogenous reinfections by Haemophilus influenzae in patients with chronic obstructive pulmonary disease: the effect of antibiotic treatment on persistence. J Infect Dis. 1990 Mar;161(3):512–517. doi: 10.1093/infdis/161.3.512. [DOI] [PubMed] [Google Scholar]
  6. Groeneveld K., van Alphen L., Voorter C., Eijk P. P., Jansen H. M., Zanen H. C. Antigenic drift of Haemophilus influenzae in patients with chronic obstructive pulmonary disease. Infect Immun. 1989 Oct;57(10):3038–3044. doi: 10.1128/iai.57.10.3038-3044.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hoiby N. Epidemiological investigations of the respiratory tract bacteriology in patients with cystic fibrosis. Acta Pathol Microbiol Scand B Microbiol Immunol. 1974 Aug;82(4):541–550. [PubMed] [Google Scholar]
  8. Hoiby N., Kilian M. Haemophilus from the lower respiratory tract of patients with cystic fibrosis. Scand J Respir Dis. 1976;57(3):103–107. [PubMed] [Google Scholar]
  9. Murphy T. F., Apicella M. A. Nontypable Haemophilus influenzae: a review of clinical aspects, surface antigens, and the human immune response to infection. Rev Infect Dis. 1987 Jan-Feb;9(1):1–15. doi: 10.1093/clinids/9.1.1. [DOI] [PubMed] [Google Scholar]
  10. Musser J. M., Barenkamp S. J., Granoff D. M., Selander R. K. Genetic relationships of serologically nontypable and serotype b strains of Haemophilus influenzae. Infect Immun. 1986 Apr;52(1):183–191. doi: 10.1128/iai.52.1.183-191.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Möller L. V., Regelink A. G., Grasselier H., Dankert-Roelse J. E., Dankert J., van Alphen L. Multiple Haemophilus influenzae strains and strain variants coexist in the respiratory tract of patients with cystic fibrosis. J Infect Dis. 1995 Nov;172(5):1388–1392. doi: 10.1093/infdis/172.5.1388. [DOI] [PubMed] [Google Scholar]
  12. Möller L. V., Ruijs G. J., Heijerman H. G., Dankert J., van Alphen L. Haemophilus influenzae is frequently detected with monoclonal antibody 8BD9 in sputum samples from patients with cystic fibrosis. J Clin Microbiol. 1992 Sep;30(9):2495–2497. doi: 10.1128/jcm.30.9.2495-2497.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Möller L. V., van Alphen L., Grasselier H., Dankert J. N-acetyl-D-glucosamine medium improves recovery of Haemophilus influenzae from sputa of patients with cystic fibrosis. J Clin Microbiol. 1993 Jul;31(7):1952–1954. doi: 10.1128/jcm.31.7.1952-1954.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Oberhofer T. R., Back A. E. Biotypes of Haemophilus encountered in clinical laboratories. J Clin Microbiol. 1979 Aug;10(2):168–174. doi: 10.1128/jcm.10.2.168-174.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Rayner R. J., Hiller E. J., Ispahani P., Baker M. Haemophilus infection in cystic fibrosis. Arch Dis Child. 1990 Mar;65(3):255–258. doi: 10.1136/adc.65.3.255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Römling U., Fiedler B., Bosshammer J., Grothues D., Greipel J., von der Hardt H., Tümmler B. Epidemiology of chronic Pseudomonas aeruginosa infections in cystic fibrosis. J Infect Dis. 1994 Dec;170(6):1616–1621. doi: 10.1093/infdis/170.6.1616. [DOI] [PubMed] [Google Scholar]
  17. Turk D. C. The pathogenicity of Haemophilus influenzae. J Med Microbiol. 1984 Aug;18(1):1–16. doi: 10.1099/00222615-18-1-1. [DOI] [PubMed] [Google Scholar]
  18. Watson K. C., Kerr E. J., Baillie M. Temporal changes in biotypes of Haemophilus influenzae isolated from patients with cystic fibrosis. J Med Microbiol. 1988 Jun;26(2):129–132. doi: 10.1099/00222615-26-2-129. [DOI] [PubMed] [Google Scholar]
  19. Watson K. C., Kerr E. J., Hinks C. A. Distribution of biotypes of Haemophilus influenzae and H parainfluenzae in patients with cystic fibrosis. J Clin Pathol. 1985 Jul;38(7):750–753. doi: 10.1136/jcp.38.7.750. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. van Alphen L. Epidemiology and prevention of respiratory tract infections due to nonencapsulated Haemophilus influenzae. J Infect Dis. 1992 Jun;165 (Suppl 1):S177–S180. doi: 10.1093/infdis/165-supplement_1-s177. [DOI] [PubMed] [Google Scholar]
  21. van Belkum A., Duim B., Regelink A., Möller L., Quint W., van Alphen L. Genomic DNA fingerprinting of clinical Haemophilus influenzae isolates by polymerase chain reaction amplification: comparison with major outer-membrane protein and restriction fragment length polymorphism analysis. J Med Microbiol. 1994 Jul;41(1):63–68. doi: 10.1099/00222615-41-1-63. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES